vs
科睿唯安（CLVT）与南玻集团（CSGS）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是南玻集团的1.9倍（$617.0M vs $323.1M）。南玻集团净利率更高（2.2% vs 0.5%，领先1.7%）。南玻集团同比增速更快（2.0% vs -6.9%）。科睿唯安自由现金流更多（$89.2M vs $55.8M）。过去两年南玻集团的营收复合增速更高（4.6% vs -0.3%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商，业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售，产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
CLVT vs CSGS — 直观对比
营收规模更大
CLVT
是对方的1.9倍
$323.1M
营收增速更快
CSGS
高出9.0%
-6.9%
净利率更高
CSGS
高出1.7%
0.5%
自由现金流更多
CLVT
多$33.4M
$55.8M
两年增速更快
CSGS
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $617.0M | $323.1M |
| 净利润 | $3.1M | $7.0M |
| 毛利率 | 66.8% | 50.0% |
| 营业利润率 | 6.7% | 9.0% |
| 净利率 | 0.5% | 2.2% |
| 营收同比 | -6.9% | 2.0% |
| 净利润同比 | 101.6% | -79.7% |
| 每股收益（稀释后） | $0.00 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTCSGS
| Q4 25 | $617.0M | $323.1M | ||
| Q3 25 | $623.1M | $303.6M | ||
| Q2 25 | $621.4M | $297.1M | ||
| Q1 25 | $593.7M | $299.5M | ||
| Q4 24 | $663.0M | $316.7M | ||
| Q3 24 | $622.2M | $295.1M | ||
| Q2 24 | $650.3M | $290.3M | ||
| Q1 24 | $621.2M | $295.1M |
净利润CLVTCSGS
| Q4 25 | $3.1M | $7.0M | ||
| Q3 25 | $-28.3M | $20.5M | ||
| Q2 25 | $-72.0M | $12.3M | ||
| Q1 25 | $-103.9M | $16.1M | ||
| Q4 24 | $-191.8M | $34.5M | ||
| Q3 24 | $-65.6M | $19.1M | ||
| Q2 24 | $-304.3M | $13.8M | ||
| Q1 24 | $-75.0M | $19.5M |
毛利率CLVTCSGS
| Q4 25 | 66.8% | 50.0% | ||
| Q3 25 | 65.0% | 48.1% | ||
| Q2 25 | 67.2% | 49.5% | ||
| Q1 25 | 65.1% | 48.4% | ||
| Q4 24 | 65.7% | 51.3% | ||
| Q3 24 | 66.2% | 49.4% | ||
| Q2 24 | 67.2% | 47.3% | ||
| Q1 24 | 64.9% | 46.5% |
营业利润率CLVTCSGS
| Q4 25 | 6.7% | 9.0% | ||
| Q3 25 | 7.1% | 10.0% | ||
| Q2 25 | 1.1% | 10.0% | ||
| Q1 25 | -3.5% | 9.8% | ||
| Q4 24 | -9.4% | 13.4% | ||
| Q3 24 | 3.5% | 10.8% | ||
| Q2 24 | -36.9% | 8.8% | ||
| Q1 24 | 0.8% | 10.8% |
净利率CLVTCSGS
| Q4 25 | 0.5% | 2.2% | ||
| Q3 25 | -4.5% | 6.7% | ||
| Q2 25 | -11.6% | 4.1% | ||
| Q1 25 | -17.5% | 5.4% | ||
| Q4 24 | -28.9% | 10.9% | ||
| Q3 24 | -10.5% | 6.5% | ||
| Q2 24 | -46.8% | 4.8% | ||
| Q1 24 | -12.1% | 6.6% |
每股收益（稀释后）CLVTCSGS
| Q4 25 | $0.00 | $0.24 | ||
| Q3 25 | $-0.04 | $0.73 | ||
| Q2 25 | $-0.11 | $0.44 | ||
| Q1 25 | $-0.15 | $0.57 | ||
| Q4 24 | $-0.27 | $1.20 | ||
| Q3 24 | $-0.09 | $0.67 | ||
| Q2 24 | $-0.46 | $0.48 | ||
| Q1 24 | $-0.14 | $0.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | $180.0M |
| 总债务越低越好 | $4.3B | $539.5M |
| 股东权益账面价值 | $4.8B | $283.7M |
| 总资产 | $11.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.89× | 1.90× |
8季度趋势，按日历期对齐
现金及短期投资CLVTCSGS
| Q4 25 | $329.2M | $180.0M | ||
| Q3 25 | $318.7M | $158.4M | ||
| Q2 25 | $362.6M | $145.9M | ||
| Q1 25 | $354.0M | $136.0M | ||
| Q4 24 | $295.2M | $161.8M | ||
| Q3 24 | $388.5M | $118.4M | ||
| Q2 24 | $376.4M | $110.4M | ||
| Q1 24 | $361.8M | $120.8M |
总债务CLVTCSGS
| Q4 25 | $4.3B | $539.5M | ||
| Q3 25 | $4.4B | $538.6M | ||
| Q2 25 | $4.5B | $537.8M | ||
| Q1 25 | $4.5B | $537.6M | ||
| Q4 24 | $4.5B | $538.5M | ||
| Q3 24 | $4.6B | $539.5M | ||
| Q2 24 | $4.6B | $540.5M | ||
| Q1 24 | $4.6B | $541.5M |
股东权益CLVTCSGS
| Q4 25 | $4.8B | $283.7M | ||
| Q3 25 | $4.9B | $289.5M | ||
| Q2 25 | $5.0B | $290.7M | ||
| Q1 25 | $5.0B | $283.1M | ||
| Q4 24 | $5.1B | $282.6M | ||
| Q3 24 | $5.5B | $288.4M | ||
| Q2 24 | $5.6B | $273.3M | ||
| Q1 24 | $5.9B | $269.3M |
总资产CLVTCSGS
| Q4 25 | $11.1B | $1.5B | ||
| Q3 25 | $11.2B | $1.5B | ||
| Q2 25 | $11.4B | $1.4B | ||
| Q1 25 | $11.5B | $1.4B | ||
| Q4 24 | $11.5B | $1.5B | ||
| Q3 24 | $12.0B | $1.4B | ||
| Q2 24 | $12.1B | $1.4B | ||
| Q1 24 | $12.5B | $1.3B |
负债/权益比CLVTCSGS
| Q4 25 | 0.89× | 1.90× | ||
| Q3 25 | 0.90× | 1.86× | ||
| Q2 25 | 0.90× | 1.85× | ||
| Q1 25 | 0.90× | 1.90× | ||
| Q4 24 | 0.88× | 1.91× | ||
| Q3 24 | 0.84× | 1.87× | ||
| Q2 24 | 0.83× | 1.98× | ||
| Q1 24 | 0.79× | 2.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.9M | $59.2M |
| 自由现金流经营现金流 - 资本支出 | $89.2M | $55.8M |
| 自由现金流率自由现金流/营收 | 14.5% | 17.3% |
| 资本支出强度资本支出/营收 | 11.5% | 1.1% |
| 现金转化率经营现金流/净利润 | 51.58× | 8.46× |
| 过去12个月自由现金流最近4个季度 | $365.3M | $141.4M |
8季度趋势，按日历期对齐
经营现金流CLVTCSGS
| Q4 25 | $159.9M | $59.2M | ||
| Q3 25 | $181.1M | $47.9M | ||
| Q2 25 | $116.3M | $37.3M | ||
| Q1 25 | $171.2M | $11.5M | ||
| Q4 24 | $141.3M | $82.5M | ||
| Q3 24 | $202.9M | $39.5M | ||
| Q2 24 | $126.2M | $43.1M | ||
| Q1 24 | $176.2M | $-29.4M |
自由现金流CLVTCSGS
| Q4 25 | $89.2M | $55.8M | ||
| Q3 25 | $115.5M | $43.9M | ||
| Q2 25 | $50.3M | $34.6M | ||
| Q1 25 | $110.3M | $7.1M | ||
| Q4 24 | $59.1M | $76.6M | ||
| Q3 24 | $126.3M | $32.0M | ||
| Q2 24 | $60.3M | $38.8M | ||
| Q1 24 | $111.8M | $-34.1M |
自由现金流率CLVTCSGS
| Q4 25 | 14.5% | 17.3% | ||
| Q3 25 | 18.5% | 14.5% | ||
| Q2 25 | 8.1% | 11.6% | ||
| Q1 25 | 18.6% | 2.4% | ||
| Q4 24 | 8.9% | 24.2% | ||
| Q3 24 | 20.3% | 10.8% | ||
| Q2 24 | 9.3% | 13.4% | ||
| Q1 24 | 18.0% | -11.6% |
资本支出强度CLVTCSGS
| Q4 25 | 11.5% | 1.1% | ||
| Q3 25 | 10.5% | 1.3% | ||
| Q2 25 | 10.6% | 0.9% | ||
| Q1 25 | 10.3% | 1.5% | ||
| Q4 24 | 12.4% | 1.9% | ||
| Q3 24 | 12.3% | 2.5% | ||
| Q2 24 | 10.1% | 1.5% | ||
| Q1 24 | 10.4% | 1.6% |
现金转化率CLVTCSGS
| Q4 25 | 51.58× | 8.46× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | 3.04× | ||
| Q1 25 | — | 0.71× | ||
| Q4 24 | — | 2.39× | ||
| Q3 24 | — | 2.07× | ||
| Q2 24 | — | 3.12× | ||
| Q1 24 | — | -1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
